Should I buy Helmerich & Payne, Inc. (HP) stock or is it too late?

Helmerich & Payne, Inc. · Energy · price $39

See the full Helmerich & Payne, Inc. (HP) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 82% of its targets hit on this sector (22 calls tested). It aims for $50 (+28 %), call made on October 13, 2026, maturing on October 13, 2027 (1 d ago).

The 1 reliable analyst $50+28 %

The 7 other firms $48+23 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $50 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Helmerich & Payne, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Guggenheim	80 %	+18.4 %	5	$80 +105%
Jefferies	54 %	+11.6 %	13	$45 +15%
RBC Capital	45 %	+10.5 %	11	$49 +25%
Citigroup	44 %	+2.3 %	16	$48 +23%
Barclays	29 %	-2.7 %	7	$51 +31%
Morgan Stanley	58 %	-3.0 %	19	$41 +5%
JP Morgan	43 %	-5.7 %	7	$34 -13%
Susquehanna	36 %	-5.8 %	14	$50 +28%

In short — Should you invest in Helmerich & Payne, Inc.? Is it too late, still worth it? Analysts are split (50% buy, median target $49, i.e. +24%), and the most reliable on HP targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $49, i.e. +24% from the current price ($39).
The most reliable firm on HP, Morgan Stanley (58% hit rate, 19 scored calls), targets $41 (call made on August 20, 2026, maturing on August 20, 2027) (+5%) in its most recent call, and $23 (call made on November 25, 2025, maturing on November 25, 2026) (-41%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 3 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on HP

Median target $49 (+24%) · 8 ratings · Hold consensus

Strong Buy00%

Buy450%

Hold338%

Sell113%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Helmerich & Payne, Inc. now?

We won't decide for you. The facts: 50% of analysts rate it a buy, median target $49 (+24%), and Morgan Stanley (most reliable on HP, 58%) targets $41. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Helmerich & Payne, Inc.?

Not according to analysts: the median target ($49) is still +24% above the current price ($39) (most reliable on HP: Morgan Stanley, 58%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Helmerich & Payne, Inc. still worth investing in?

It depends on the gap between the price ($39) and its estimated value: analysts target $49 on median (+24%), with 50% buys (most reliable on HP: Morgan Stanley, 58%). Cross-check with their real reliability on HP and the cautions above. Information, not advice.

What's the main risk in buying HP?

The consensus is not unanimous: of 8 ratings, 3 are neutral and 1 is a sell.

→ Go deeper: the full Helmerich & Payne, Inc. profile (consensus, analyst reliability, price target, performance).